← Who reports today · Health Care
GEHC · Q2 2026
Archived report (Q2 2026). Latest deep dive →
The quarter in brief
GE HealthCare's revenue grew 5.7% to $5.3B, operating income rose 13.0% to $739M and net income 15.4% to $561M, lifting diluted EPS 16.5% to $1.24.
Net income attributable to GE HealthCare
$561M
up 15.4% y/y
Total revenues
$5,295M
up 5.8% y/y
Operating income
$739M
up 13.0% y/y
Gross profit
$2,180M
up 9.8% y/y
All figures in $M.
| Line item | Amount and change |
|---|---|
| Sales of products | $3,416 · +4.7% |
| Sales of services | $1,878 · +7.7% |
| Total revenues | $5,295 · +5.8% |
| Cost of products | $2,217 · +2.6% |
| Cost of services | $898 · +4.1% |
| Gross profit | $2,180 · +9.8% · 41.2% margin |
| Selling, general, and administrative | $1,118 · +8.6% |
| Research and development | $323 · +7.0% |
| Operating income | $739 · +13.0% · 14.0% margin |
| Interest and other financial charges – net | $114 · +0.9% |
| Non-operating benefit (income) costs | $45 · −38.4% |
| Other (income) expense – net | $22 · vs −$1 |
| Income before income taxes | $693 · +13.1% |
| Benefit (provision) for income taxes | $119 · +5.3% · 17.2% effective rate |
| Net (income) loss attributable to noncontrolling interests | $13 · −7.1% |
| Net income attributable to GE HealthCare | $561 · +15.4% · $1.24/sh · 10.6% margin |
Verdict: GE HealthCare's revenue grew 5.7% to $5.3B, operating income rose 13.0% to $739M and net income 15.4% to $561M, lifting diluted EPS 16.5% to $1.24.
Source and notation
Source: GEHC press release, 8-K EX-99.1 of 07/29/2026 (SEC EDGAR).
Open as an image: GEHC, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “GEHC Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/gehc/q2-2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/gehc/q2-2026"><img src="https://whoreportstoday.com/t/gehc/q2-2026/sankey.png" alt="GEHC Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/gehc/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/gehc/q2-2026/sankey.png
<a href="https://whoreportstoday.com/t/gehc/q2-2026">GEHC Q2 2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Record organic orders growth was 11.1%, with book-to-bill of 1.15 times and backlog of $23.9 billion.
- Operating income was $739M (+13.0% y/y), an operating margin of 14.0% vs 13.1% a year ago.
- Gross profit of $2.18B is a gross margin of 41.2% vs 39.6% a year ago.
- Income tax of $119M implies an effective rate of 17.2% vs 18.4% a year ago.
- Diluted EPS was $1.24 vs $1.06 a year ago (+17.0%), while net income changed +15.4%.
What distorts the picture in this report and what to watch beyond the headlines.
GEHC — a medical technology company that sells imaging equipment, ultrasound, patient monitoring systems, contrast agents and radiopharmaceuticals, along with software and services, to hospitals and clinics worldwide.
It reports four segments: Imaging, Advanced Visualization Solutions (specialized ultrasound and procedural guidance), Patient Care Solutions and Pharmaceutical Diagnostics. · Source: annual report (Form 10-K, SEC)
More reports: GILD · Q2 2026 · HCA · Q2 2026 · HSIC · Q2 2026 · HUM · Q2 2026 · IDXX · Q2 2026 · ILMN · Q2 2026 · INCY · Q2 2026 · IQV · Q2 2026 · ISRG · Q3 2026 · JNJ · Q3 2026 · all reports